Spero Therapeutics, Inc.
USD2.26
+0.00 (+0.00%)
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.25
Prev. Close
$2.26
Day Low
$2.25
Day High
$2.33
52W Low
$1.80
52W High
$3.22
Market Cap
$0.13B
Volume
0.52M
| -0.8 |
| 31 Dec 2023 | FY | 50.4% | 22.0% | 21.3% | 12.5% | 0.05 | 3.53 | 3.4 |
| 31 Dec 2022 | FY | 100.0% | -95.5% | -61.1% | -37.2% | 0.09 | 5.04 | -1.4 |
| 31 Dec 2021 | FY | 100.0% | -2923.6% | -101.7% | -52.5% | 0.08 | 8.46 | -5.5 |
| 31 Dec 2020 | FY | -618.1% | -839.0% | -59.3% | -51.0% | 0.06 | 9.70 | -5.5 |
| 31 Dec 2019 | FY | -262.5% | -335.7% | -81.7% | -57.4% | 0.07 | 3.58 | -2.9 |
| 31 Dec 2018 | FY | -754.4% | -1050.5% | -36.0% | -32.3% | 0.00 | 9.37 | -2.4 |
| 31 Dec 2017 | FY | -1560.9% | -2329.3% | -54.3% | -49.3% | 0.00 | 10.70 | -0.7 |
| 31 Dec 2016 | FY | -7760.6% | -7609.3% | -250.7% | -185.1% | 0.00 | 1.72 | -3.0 |
| 1.0 |
| 30 Sept 2025 | Q3 | 100.0% | -242.2% | -27.9% | -13.6% | 0.13 | 3.83 | -3.6 |
| 30 Jun 2025 | Q2 | 100.0% | -14.4% | -5.2% | -2.7% | 0.11 | 3.97 | -23.9 |
| 31 Mar 2025 | Q1 | -131.6% | -236.1% | -41.0% | -17.8% | 0.12 | 2.56 | -0.7 |
| 31 Dec 2024 | Q4 | -529.0% | -138.8% | -45.3% | -18.9% | 0.09 | 2.19 | -0.7 |
| 30 Sept 2024 | Q3 | 100.0% | -127.3% | -26.2% | -12.7% | 0.07 | 2.68 | -1.1 |
| 30 Jun 2024 | Q2 | -132.7% | -175.2% | -22.2% | -11.9% | 0.06 | 2.68 | -1.0 |
| 31 Mar 2024 | Q1 | 100.0% | -301.4% | -13.2% | -7.6% | 0.05 | 3.35 | -1.9 |
| 31 Dec 2023 | Q4 | 32.8% | 69.6% | 47.9% | 28.1% | 0.05 | 3.53 | 0.4 |